Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.200
+0.230 (7.74%)
At close: Nov 22, 2024, 4:00 PM
3.260
+0.060 (1.87%)
After-hours: Nov 22, 2024, 5:28 PM EST
Prime Medicine Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 117.98 | 41.57 | 187.62 | 185.42 | 36.98 | 8.65 |
Short-Term Investments | 57.55 | 80.09 | 106.3 | 84.2 | 16.35 | - |
Cash & Short-Term Investments | 175.53 | 121.67 | 293.92 | 269.62 | 53.33 | 8.65 |
Cash Growth | 6.18% | -58.61% | 9.01% | 405.59% | 516.72% | - |
Prepaid Expenses | 6.01 | 19.06 | 2.45 | 0.96 | 0.07 | 0.05 |
Other Current Assets | 9.54 | 2.25 | 0.25 | - | - | - |
Total Current Assets | 246.07 | 142.98 | 296.62 | 270.58 | 53.4 | 8.7 |
Property, Plant & Equipment | 72.65 | 36.6 | 48.55 | 15.68 | 0.6 | - |
Other Long-Term Assets | 14.06 | 14.28 | 15.14 | 15.6 | 0.79 | - |
Total Assets | 332.78 | 193.85 | 360.31 | 301.86 | 54.78 | 8.7 |
Accounts Payable | 5.43 | 19.54 | 4.33 | 1.44 | 0.25 | - |
Accrued Expenses | 17.28 | 10.54 | 9.02 | 36.19 | 0.74 | 0.54 |
Short-Term Debt | - | - | - | - | 17.52 | - |
Current Portion of Leases | 4.48 | 9.28 | 11.69 | 7.34 | - | - |
Other Current Liabilities | 1.4 | 17.07 | 1.67 | 13.02 | 0.93 | 6.77 |
Total Current Liabilities | 37.88 | 56.42 | 26.71 | 57.98 | 19.44 | 7.31 |
Long-Term Leases | 36.76 | 4.36 | 17.05 | 3.07 | - | - |
Long-Term Deferred Tax Liabilities | - | - | 0.28 | 1.24 | 1.87 | - |
Total Liabilities | 143.28 | 60.78 | 44.04 | 62.3 | 21.31 | 7.31 |
Common Stock | 0 | 0 | 0 | - | - | 0 |
Additional Paid-In Capital | 834.42 | 624.41 | 609.85 | 15.16 | 8.35 | - |
Retained Earnings | -644.94 | -491.33 | -293.2 | -171.38 | -6.01 | -2.6 |
Comprehensive Income & Other | 0.02 | -0.02 | -0.38 | -0.03 | - | - |
Total Common Equity | 189.5 | 133.07 | 316.27 | -156.24 | 2.34 | -2.6 |
Shareholders' Equity | 189.5 | 133.07 | 316.27 | 239.56 | 33.47 | 1.39 |
Total Liabilities & Equity | 332.78 | 193.85 | 360.31 | 301.86 | 54.78 | 8.7 |
Total Debt | 41.25 | 13.63 | 28.75 | 10.41 | 17.52 | - |
Net Cash (Debt) | 134.28 | 108.03 | 265.18 | 259.21 | 35.81 | 8.65 |
Net Cash Growth | -9.44% | -59.26% | 2.30% | 623.80% | 314.17% | - |
Net Cash Per Share | 1.23 | 1.19 | 7.82 | 19.98 | 13.57 | 5.82 |
Filing Date Shares Outstanding | 127.6 | 115.2 | 88.4 | 17.06 | 24.32 | 1.49 |
Total Common Shares Outstanding | 127.6 | 92.64 | 88.36 | 17.06 | 24.32 | 1.49 |
Working Capital | 208.19 | 86.55 | 269.9 | 212.6 | 33.96 | 1.39 |
Book Value Per Share | 1.49 | 1.44 | 3.58 | -9.16 | 0.10 | -1.75 |
Tangible Book Value | 189.5 | 133.07 | 316.27 | -156.24 | 2.34 | -2.6 |
Tangible Book Value Per Share | 1.49 | 1.44 | 3.58 | -9.16 | 0.10 | -1.75 |
Machinery | 27.95 | 24.16 | 19.67 | 5.42 | 0.64 | - |
Construction In Progress | 1.75 | 5.4 | 1.61 | - | - | - |
Leasehold Improvements | 5.46 | 0.58 | 0.56 | 0.13 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.